Article info
PDFOriginal research
Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
- Correspondence to Mr Borja Marcos Ribes, Department of Pharmacy, Hospital Universitari Sant Joan d'Alacant, Sant Joan d'Alacant 03550, Spain; borjamarcosribes{at}gmail.com
Citation
Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
Publication history
- Received November 20, 2018
- Revised March 2, 2019
- Accepted March 12, 2019
- First published May 7, 2019.
Online issue publication
June 08, 2022
Article Versions
- Previous version (23 October 2020).
- Previous version (23 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.